Inner Fire Loss of Libido NDC 76472-7017

NDC codes

FDA NDC Directory

Product NDC (as listed)76472-7017Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76472-7017Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76472-7017-2	76472701702	1 BOTTLE, SPRAY in 1 BOX (76472-7017-2) / 30 mL in 1 BOTTLE, SPRAY (76472-7017-1)Marketed from Aug 14, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Inner Fire Loss of LibidoSuffix: Loss of Libido
Generic name (nonproprietary): avena sativa 3c, staphysagria 9c, agnus castus 5c
Active ingredients: Vitex agnus-castus whole — .1 mg/100mLAvena sativa flowering top — .1 mg/100mLDelphinium staphisagria seed — .1 mg/100mL
Dosage form: Spray
Route: Buccal
Labeler: SEVENE USA
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Aug 14, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 76472-7017_58ea6383-113b-8231-e063-6294a90a2c91SPL ID 58ea6383-113b-8231-e063-6294a90a2c91SPL set ID 5511c22e-3e23-a2e1-e063-6394a90a1eceUNII 9HDT03PZ0N, MA9CQJ3F7F, 00543AP1JV

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Buccal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476472701702 followed by a unit qualifier and the quantity

Package 76472-7017-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 13, 2026.

Indications (excerpt from the label)

AVENA SATIVA General Weakness - Loss of Appetite - Sleeplessness - Fatigue – Nervous Exhaustion .* STAPHYSAGRIA Irritability - Incision discomfort – Minor cuts & Surgical wounds .* AGNUS CASTUS Sexual debility - Hormonal imbalance - Emotional Exhaustion when Associated with Loss of Libido .*

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)